NEXVIAZYME

Google image searchProduct monograph

Active ingredient

avalglucosidase alfa, 100 MG/VIAL

DIN: 02522365

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 09-FEB-2022

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB22 — AVALGLUCOSIDASE ALFA (ATC/DDD)

Reference brand drug: Nexviazyme

External Links for Nexviazyme

Search on Google

• Nexviazyme side effects
• Nexviazyme dosage
• avalglucosidase alfa side effects
• avalglucosidase alfa dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find nexviazyme photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.